Literature DB >> 31811638

Diverging RNPs: Toward Understanding lncRNA-Protein Interactions and Functions.

Martin Sauvageau1,2.   

Abstract

RNA-protein interactions are essential to a variety of biological processes. The realization that mammalian genomes are pervasively transcribed brought a tidal wave of tens of thousands of newly identified long noncoding RNAs (lncRNAs) and raised questions about their purpose in cells. The vast majority of lncRNAs have yet to be studied, and it remains to be determined to how many of these transcripts a function can be ascribed. However, results gleaned from studying a handful of these macromolecules have started to reveal common themes of biological function and mechanism of action involving intricate RNA-protein interactions. Some lncRNAs were shown to regulate the chromatin and transcription of distant and neighboring genes in the nucleus, while others regulate the translation or localization of proteins in the cytoplasm. Some lncRNAs were found to be crucial during development, while mutations and aberrant expression of others have been associated with several types of cancer and a plethora of diseases. Over the last few years, the establishment of new technologies has been key in providing the tools to decode the rules governing lncRNA-protein interactions and functions. This chapter will highlight the general characteristics of lncRNAs, their function, and their mode of action, with a special focus on protein interactions. It will also describe the methods at the disposition of scientists to help them cross this next frontier in our understanding of lncRNA biology.

Entities:  

Keywords:  Functional RNAs; Long noncoding RNAs; RNA biology; RNA-protein interactions; Ribonucleoprotein complexes

Year:  2019        PMID: 31811638     DOI: 10.1007/978-3-030-31434-7_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Hypoxia-induced LncRNA DACT3-AS1 upregulates PKM2 to promote metastasis in hepatocellular carcinoma through the HDAC2/FOXA3 pathway.

Authors:  Liyan Wang; Bin Li; Xiaotong Bo; Xiaoyuan Yi; Xuhua Xiao; Qinghua Zheng
Journal:  Exp Mol Med       Date:  2022-06-28       Impact factor: 12.153

2.  A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signaling.

Authors:  Suofeng Sun; Jing Gao; Shen Zhou; Yuan Li; Yu Wang; Li Jin; Jian Li; Bowei Liu; Bingyong Zhang; Shuangyin Han; Hui Ding; Xiuling Li
Journal:  J Exp Clin Cancer Res       Date:  2020-11-23

Review 3.  The Emerging Role of Circ-SHPRH in Cancer.

Authors:  Xinyue Ju; Yan Tang; Rongfeng Qu; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2021-07-13       Impact factor: 4.147

4.  Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.

Authors:  Dong-Yan Zhang; Qing-Can Sun; Xue-Jing Zou; Yang Song; Wen-Wen Li; Ze-Qin Guo; Shan-Shan Liu; Li Liu; De-Hua Wu
Journal:  J Exp Clin Cancer Res       Date:  2020-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.